A single-cell atlas of the peripheral immune response in patients with severe COVID-19
…, T Hollis, LJ Simpson, P Grant, A Subramanian… - Nature medicine, 2020 - nature.com
There is an urgent need to better understand the pathophysiology of Coronavirus disease
2019 (COVID-19), the global pandemic caused by SARS-CoV-2, which has infected more …
2019 (COVID-19), the global pandemic caused by SARS-CoV-2, which has infected more …
Remdesivir for 5 or 10 days in patients with severe Covid-19
…, KT Tashima, G Diaz, A Subramanian - … England Journal of …, 2020 - Mass Medical Soc
Background Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We …
[HTML][HTML] Outcomes of kidney transplantation in HIV-infected recipients
…, E Blumberg, D Simon, A Subramanian… - … England Journal of …, 2010 - Mass Medical Soc
Background The outcomes of kidney transplantation and immunosuppression in people
infected with human immunodeficiency virus (HIV) are incompletely understood. Methods We …
infected with human immunodeficiency virus (HIV) are incompletely understood. Methods We …
Structural analysis of α-enolase: Mapping the functional domains involved in down-regulation of the c-myc protooncogene
A Subramanian, DM Miller - Journal of Biological Chemistry, 2000 - ASBMB
Myc-binding protein-1 (MBP-1) is a 37-kDa protein with sequence homology to the 3′
portion of the α-enolase gene. α-Enolase is a 48-kDa protein, which plays a critical role in the …
portion of the α-enolase gene. α-Enolase is a 48-kDa protein, which plays a critical role in the …
[HTML][HTML] Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
…, A Asuni, T Ranganath, PM Grant, A Subramanian… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND Elevated levels of inflammatory cytokines have been associated with poor
outcomes among COVID-19 patients. It is unknown, however, how these levels compare with …
outcomes among COVID-19 patients. It is unknown, however, how these levels compare with …
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
…, B Pulendran, U Singh, A Subramanian… - Science Translational …, 2022 - science.org
A damaging inflammatory response is implicated in the pathogenesis of severe coronavirus
disease 2019 (COVID-19), but mechanisms contributing to this response are unclear. In two …
disease 2019 (COVID-19), but mechanisms contributing to this response are unclear. In two …
Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe …
…, M Rao, H Bonilla, A Subramanian… - Clinical Infectious …, 2021 - academic.oup.com
To assess the prevalence of persistent functional impairment after coronavirus disease (COVID-19),
we assessed 118 individuals 3–4 months after their initial COVID-19 diagnosis with …
we assessed 118 individuals 3–4 months after their initial COVID-19 diagnosis with …
[PDF][PDF] Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
…, J Fung, KE Sherman, A Subramanian… - Liver …, 2012 - Wiley Online Library
Hepatitis C virus (HCV) is a controversial indication for liver transplantation (LT) in human
immunodeficiency virus (HIV)–infected patients because of reportedly poor outcomes. This …
immunodeficiency virus (HIV)–infected patients because of reportedly poor outcomes. This …
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 …
…, H Sharifi, A Horomanski, A Subramanian… - Frontiers in …, 2023 - frontiersin.org
Background The global prevalence of PASC is estimated to be present in 0·43 and based on
the WHO estimation of 470 million worldwide COVID-19 infections, corresponds to around …
the WHO estimation of 470 million worldwide COVID-19 infections, corresponds to around …
Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery
AA John, AP Subramanian… - International journal …, 2015 - Taylor & Francis
Neuroregeneration is the regrowth or repair of nervous tissues, cells, or cell products involved
in neurodegeneration and inflammatory diseases of the nervous system like Alzheimer’s …
in neurodegeneration and inflammatory diseases of the nervous system like Alzheimer’s …
